U.S. approves remdesivir drug as emergency treatment for COVID-19

Published - May 02, 2020 04:38 am IST - WASHINGTON

The U.S. Food and Drug Administration (FDA) has granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug remdesivir to treat patients with COVID-19 , it said in a letter to Gilead.

During a meeting in the Oval Office with President Donald Trump, Gilead Chief Executive Daniel O'Day called the move an important first step and said the company was donating 1 million vials of the drug to help patients.

Gilead said on Wednesday the drug had helped improve outcomes for patients with COVID-19 , the disease caused by the coronavirus, and provided data suggesting it worked better when given earlier in the course of infection.

The closely watched drug has moved financial markets in recent weeks, following the release of several studies that painted a mixed picture of its effectiveness.

Vice President Mike Pence said the 1 million vials would start being distributed to hospitals on Monday.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.